MX2012001419A - Compuestos biciclicos novedosos de urea. - Google Patents
Compuestos biciclicos novedosos de urea.Info
- Publication number
- MX2012001419A MX2012001419A MX2012001419A MX2012001419A MX2012001419A MX 2012001419 A MX2012001419 A MX 2012001419A MX 2012001419 A MX2012001419 A MX 2012001419A MX 2012001419 A MX2012001419 A MX 2012001419A MX 2012001419 A MX2012001419 A MX 2012001419A
- Authority
- MX
- Mexico
- Prior art keywords
- urea compounds
- novel bicyclic
- bicyclic urea
- novel
- cancer
- Prior art date
Links
- -1 bicyclic urea compounds Chemical class 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000003463 hyperproliferative effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23187309P | 2009-08-06 | 2009-08-06 | |
| PCT/US2010/043467 WO2011017142A1 (en) | 2009-08-06 | 2010-07-28 | Novel bicyclic urea compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012001419A true MX2012001419A (es) | 2012-03-16 |
Family
ID=42985363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012001419A MX2012001419A (es) | 2009-08-06 | 2010-07-28 | Compuestos biciclicos novedosos de urea. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8569295B2 (enExample) |
| EP (1) | EP2461869B1 (enExample) |
| JP (1) | JP5718332B2 (enExample) |
| KR (1) | KR20120055608A (enExample) |
| CN (1) | CN102573994B (enExample) |
| AU (1) | AU2010281368C1 (enExample) |
| CA (1) | CA2770156C (enExample) |
| EA (1) | EA201200218A1 (enExample) |
| ES (1) | ES2433230T3 (enExample) |
| IL (1) | IL217651A (enExample) |
| MX (1) | MX2012001419A (enExample) |
| SG (1) | SG178271A1 (enExample) |
| WO (1) | WO2011017142A1 (enExample) |
| ZA (1) | ZA201201635B (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009303602B2 (en) | 2008-10-14 | 2012-06-14 | Sunshine Lake Pharma Co., Ltd. | Compounds and methods of use |
| EP2408300B1 (en) | 2009-03-21 | 2016-05-11 | Sunshine Lake Pharma Co., Ltd. | Amino ester derivatives, salts thereof and methods of use |
| US9290485B2 (en) | 2010-08-04 | 2016-03-22 | Novartis Ag | N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides |
| MX352844B (es) | 2011-02-28 | 2017-12-11 | Calitor Sciences Llc | Compuestos de quinolina sustituidos y metodos de uso. |
| US9283225B2 (en) | 2011-08-10 | 2016-03-15 | Merck Patent Gmbh | Pyrido-pyrimidine derivatives |
| GB201201566D0 (en) | 2012-01-30 | 2012-03-14 | Vernalis R&D Ltd | New chemical compounds |
| EP2879677B1 (en) | 2012-07-28 | 2017-06-14 | Calitor Sciences, LLC | Substituted pyrazolone compounds and methods of use |
| US8975282B2 (en) | 2012-07-28 | 2015-03-10 | Sunshine Lake Pharma Co., Ltd. | Substituted pyrazolone compounds and methods of use |
| WO2014032755A2 (en) | 2012-08-29 | 2014-03-06 | Merck Patent Gmbh | Ddr2 inhibitors for the treatment of osteoarthritis |
| KR101823488B1 (ko) | 2013-10-14 | 2018-01-30 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 선택적으로 치환된 퀴놀린 화합물 |
| ES2670550T3 (es) | 2013-10-14 | 2018-05-30 | Eisai R&D Management Co., Ltd. | Derivados de quinolina selectivamente sustituidos |
| CN106279147A (zh) | 2015-05-21 | 2017-01-04 | 中国科学院上海药物研究所 | 一种吡啶并氮杂环化合物及其制备方法和用途 |
| EP3440052B1 (en) * | 2016-04-06 | 2023-10-25 | University Of Oulu | Compounds for use in the treatment of cancer |
| WO2018215668A1 (en) * | 2017-05-26 | 2018-11-29 | Glenmark Pharmaceuticals S.A. | Novel inhibitors of map4k1 |
| GB2575490A (en) * | 2018-07-12 | 2020-01-15 | Recordati Ind Chimica E Farmaceutica Spa | P2X3 receptor antagonists |
| PT3842425T (pt) * | 2018-08-24 | 2024-07-02 | Transthera Sciences Nanjing Inc | Novo inibidor derivado de quinolina |
| US12378245B2 (en) * | 2019-02-11 | 2025-08-05 | Phoenix Molecular Designs | Crystalline forms of an RSK inhibitor |
| CN112625026B (zh) * | 2019-09-24 | 2022-09-09 | 药捷安康(南京)科技股份有限公司 | Tam家族激酶抑制剂的喹啉衍生物 |
| IL296790B1 (en) | 2020-03-30 | 2026-07-01 | Hutchmed Ltd | Amide compounds and their uses |
| CN112225748B (zh) * | 2020-10-20 | 2021-11-30 | 四川大学华西医院 | 一种具有flt3激酶抑制活性的小分子化合物及其应用 |
| WO2022175514A1 (en) | 2021-02-22 | 2022-08-25 | Bayer Aktiengesellschaft | N-(pyridin-2-yl)-acetamides as p2x3 inhibitors |
| KR102726416B1 (ko) * | 2021-12-15 | 2024-11-05 | 한국과학기술연구원 | 엑토뉴클레오티드 피로포스파타아제-포스포디에스터라아제의 저해 활성을 갖는 신규한 피리도피리미딘 유도체 및 이들의 용도 |
| JP2025500917A (ja) | 2021-12-16 | 2025-01-15 | キネート バイオファーマ インク． | Ｍｅｔキナーゼの阻害剤 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2486530A1 (en) * | 2002-05-29 | 2003-12-11 | Amgen Inc. | 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders |
| DE102004004731A1 (de) * | 2004-01-30 | 2005-08-18 | Merck Patent Gmbh | Harnstoffderivate |
| AU2006222563A1 (en) * | 2005-03-08 | 2006-09-14 | Biota Scientific Management Pty Ltd. | Bicyclic nucleosides and nucleotides as therapeutic agents |
| JP2008545660A (ja) | 2005-05-20 | 2008-12-18 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼ阻害剤として有用なピロロピリジン化合物 |
-
2010
- 2010-07-28 KR KR1020127005845A patent/KR20120055608A/ko not_active Withdrawn
- 2010-07-28 EA EA201200218A patent/EA201200218A1/ru unknown
- 2010-07-28 ES ES10739442T patent/ES2433230T3/es active Active
- 2010-07-28 SG SG2012008074A patent/SG178271A1/en unknown
- 2010-07-28 JP JP2012523650A patent/JP5718332B2/ja not_active Expired - Fee Related
- 2010-07-28 EP EP10739442.1A patent/EP2461869B1/en not_active Not-in-force
- 2010-07-28 WO PCT/US2010/043467 patent/WO2011017142A1/en not_active Ceased
- 2010-07-28 CN CN201080034738.XA patent/CN102573994B/zh not_active Expired - Fee Related
- 2010-07-28 MX MX2012001419A patent/MX2012001419A/es unknown
- 2010-07-28 AU AU2010281368A patent/AU2010281368C1/en not_active Ceased
- 2010-07-28 CA CA2770156A patent/CA2770156C/en not_active Expired - Fee Related
- 2010-07-28 US US13/388,952 patent/US8569295B2/en not_active Expired - Fee Related
-
2012
- 2012-01-19 IL IL217651A patent/IL217651A/en active IP Right Grant
- 2012-03-05 ZA ZA2012/01635A patent/ZA201201635B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011017142A1 (en) | 2011-02-10 |
| JP5718332B2 (ja) | 2015-05-13 |
| EA201200218A1 (ru) | 2012-09-28 |
| AU2010281368A1 (en) | 2012-03-22 |
| ZA201201635B (en) | 2012-11-28 |
| CN102573994A (zh) | 2012-07-11 |
| US20120190654A1 (en) | 2012-07-26 |
| KR20120055608A (ko) | 2012-05-31 |
| CN102573994B (zh) | 2015-06-24 |
| SG178271A1 (en) | 2012-03-29 |
| AU2010281368B2 (en) | 2016-04-14 |
| AU2010281368C1 (en) | 2016-08-04 |
| EP2461869B1 (en) | 2013-08-21 |
| US8569295B2 (en) | 2013-10-29 |
| ES2433230T3 (es) | 2013-12-10 |
| CA2770156A1 (en) | 2011-02-10 |
| CA2770156C (en) | 2019-02-12 |
| IL217651A (en) | 2017-08-31 |
| EP2461869A1 (en) | 2012-06-13 |
| JP2013501047A (ja) | 2013-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012001413A (es) | Compuestos azaheterociclicos novedosos. | |
| MY160468A (en) | Novel amino azaheterocyclic carboxamides | |
| EA201200218A1 (ru) | Новые бициклические соединения мочевины | |
| MX2014002836A (es) | Derivados de aminopirimidina para usarse como moduladores de la actividad de cinasa. | |
| MX355325B (es) | Quinazolincarboxamida azetidinas. | |
| WO2012013282A8 (en) | Bicyclic azaheterocyclic carboxamides as inhibitors of the kinase p70s6k | |
| MX2011009780A (es) | Pirimidinas sustituidas para el tratamiento del cancer. | |
| MY151342A (en) | Phenylamino isonicotinamide compounds | |
| IN2012DN02081A (enExample) | ||
| SG176015A1 (en) | Antiviral compounds | |
| TN2014000138A1 (en) | Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases. | |
| EA201101650A1 (ru) | Новые производные пиримидина и их применение в лечении злокачественных новообразований и последующих заболеваний | |
| TW201240990A (en) | Antiviral compounds | |
| MX2013010898A (es) | Novedoso derivados de la pirimidina. | |
| TN2011000259A1 (en) | Substituted pyrimidines for the treatment of diseases such as cancer | |
| PH12013501600A1 (en) | Novel heterocyclic derivatives | |
| MX2013012652A (es) | Derivados de n-[(1h-pirazol-1-il)aril]-1h-indol o 1h-indazol-3-carboxamida, su preparacion y su uso como antagonistas p2y12. | |
| MX346095B (es) | Nuevas imidazol-aminas como moduladores de la actividad de cinasas. | |
| MX2011008899A (es) | Nuevas orto-aminoamidas para el tratamiento del cancer. | |
| MX343377B (es) | Carboxamidas azaheterocilcicas de amina ciclica. | |
| MX2012001620A (es) | Derivados de n1-acil-5-fluoropirimidinona. | |
| WO2014086453A8 (en) | Azaheterobicyclic compounds | |
| MX353062B (es) | Nuevas carboxamidas heterociclicas como moduladores de la activadad de cinasas. | |
| NZ609924A (en) | Porphyrin treatment of neurodegenerative diseases | |
| TN2010000583A1 (en) | Organic compounds |